Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 67 Pages

Report ld: 5352980

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Injectable Implant Urinary Incontinence Device Market Size(US$)

CAGR 2025-2031

5.9%

Market Size,2031

USD 185

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 131 million

Market Forecast in 2031(Value)

US$ 185 million

CAGR

5.9%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Injectable Implant Urinary Incontinence Device market competitiveness, regional economic performance, and supply chain configurations.

Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The global Injectable Implant Urinary Incontinence Device market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Boston Scientific
Laborie Medical
Urogyn B.V.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Stress Incontinence
Urge Incontinence
Overflow Incontinence
Functional Incontinence
Others

Segment by Application

Hospitals and Clinics
Ambulatory Surgery Centres
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Injectable Implant Urinary Incontinence Device market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Urge Incontinence in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Ambulatory Surgery Centres in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Injectable Implant Urinary Incontinence Device value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Injectable Implant Urinary Incontinence Device Product Scope

1.2 Injectable Implant Urinary Incontinence Device by Type

1.2.1 Global Injectable Implant Urinary Incontinence Device Sales by Type (2020 & 2024 & 2031)

1.2.2 Stress Incontinence

1.2.3 Urge Incontinence

1.2.4 Overflow Incontinence

1.2.5 Functional Incontinence

1.2.6 Others

1.3 Injectable Implant Urinary Incontinence Device by Application

1.3.1 Global Injectable Implant Urinary Incontinence Device Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgery Centres

1.3.4 Others

1.4 Global Injectable Implant Urinary Incontinence Device Market Estimates and Forecasts (2020-2031)

1.4.1 Global Injectable Implant Urinary Incontinence Device Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Injectable Implant Urinary Incontinence Device Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Injectable Implant Urinary Incontinence Device Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Injectable Implant Urinary Incontinence Device Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Injectable Implant Urinary Incontinence Device Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Injectable Implant Urinary Incontinence Device Sales Market Share by Region (2020-2025)

2.2.2 Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Region (2020-2025)

2.3 Global Injectable Implant Urinary Incontinence Device Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Injectable Implant Urinary Incontinence Device Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Injectable Implant Urinary Incontinence Device Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Injectable Implant Urinary Incontinence Device Market Size and Prospective (2020-2031)

2.4.2 Europe Injectable Implant Urinary Incontinence Device Market Size and Prospective (2020-2031)

2.4.3 China Injectable Implant Urinary Incontinence Device Market Size and Prospective (2020-2031)

2.4.4 Japan Injectable Implant Urinary Incontinence Device Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Injectable Implant Urinary Incontinence Device Historic Market Review by Type (2020-2025)

3.1.1 Global Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025)

3.1.2 Global Injectable Implant Urinary Incontinence Device Revenue by Type (2020-2025)

3.1.3 Global Injectable Implant Urinary Incontinence Device Price by Type (2020-2025)

3.2 Global Injectable Implant Urinary Incontinence Device Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Injectable Implant Urinary Incontinence Device Sales Forecast by Type (2026-2031)

3.2.2 Global Injectable Implant Urinary Incontinence Device Revenue Forecast by Type (2026-2031)

3.2.3 Global Injectable Implant Urinary Incontinence Device Price Forecast by Type (2026-2031)

3.3 Different Types Injectable Implant Urinary Incontinence Device Representative Players

4 Global Market Size by Application

4.1 Global Injectable Implant Urinary Incontinence Device Historic Market Review by Application (2020-2025)

4.1.1 Global Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025)

4.1.2 Global Injectable Implant Urinary Incontinence Device Revenue by Application (2020-2025)

4.1.3 Global Injectable Implant Urinary Incontinence Device Price by Application (2020-2025)

4.2 Global Injectable Implant Urinary Incontinence Device Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Injectable Implant Urinary Incontinence Device Sales Forecast by Application (2026-2031)

4.2.2 Global Injectable Implant Urinary Incontinence Device Revenue Forecast by Application (2026-2031)

4.2.3 Global Injectable Implant Urinary Incontinence Device Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Injectable Implant Urinary Incontinence Device Application

5 Competition Landscape by Players

5.1 Global Injectable Implant Urinary Incontinence Device Sales by Players (2020-2025)

5.2 Global Top Injectable Implant Urinary Incontinence Device Players by Revenue (2020-2025)

5.3 Global Injectable Implant Urinary Incontinence Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2024)

5.4 Global Injectable Implant Urinary Incontinence Device Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Product Type & Application

5.7 Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Injectable Implant Urinary Incontinence Device Sales by Company

6.1.1.1 North America Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025)

6.1.1.2 North America Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025)

6.1.2 North America Injectable Implant Urinary Incontinence Device Sales Breakdown by Type (2020-2025)

6.1.3 North America Injectable Implant Urinary Incontinence Device Sales Breakdown by Application (2020-2025)

6.1.4 North America Injectable Implant Urinary Incontinence Device Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Injectable Implant Urinary Incontinence Device Sales by Company

6.2.1.1 Europe Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025)

6.2.1.2 Europe Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025)

6.2.2 Europe Injectable Implant Urinary Incontinence Device Sales Breakdown by Type (2020-2025)

6.2.3 Europe Injectable Implant Urinary Incontinence Device Sales Breakdown by Application (2020-2025)

6.2.4 Europe Injectable Implant Urinary Incontinence Device Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Injectable Implant Urinary Incontinence Device Sales by Company

6.3.1.1 China Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025)

6.3.1.2 China Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025)

6.3.2 China Injectable Implant Urinary Incontinence Device Sales Breakdown by Type (2020-2025)

6.3.3 China Injectable Implant Urinary Incontinence Device Sales Breakdown by Application (2020-2025)

6.3.4 China Injectable Implant Urinary Incontinence Device Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Injectable Implant Urinary Incontinence Device Sales by Company

6.4.1.1 Japan Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025)

6.4.1.2 Japan Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025)

6.4.2 Japan Injectable Implant Urinary Incontinence Device Sales Breakdown by Type (2020-2025)

6.4.3 Japan Injectable Implant Urinary Incontinence Device Sales Breakdown by Application (2020-2025)

6.4.4 Japan Injectable Implant Urinary Incontinence Device Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Boston Scientific

7.1.1 Boston Scientific Company Information

7.1.2 Boston Scientific Business Overview

7.1.3 Boston Scientific Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Boston Scientific Injectable Implant Urinary Incontinence Device Products Offered

7.1.5 Boston Scientific Recent Development

7.2 Laborie Medical

7.2.1 Laborie Medical Company Information

7.2.2 Laborie Medical Business Overview

7.2.3 Laborie Medical Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Laborie Medical Injectable Implant Urinary Incontinence Device Products Offered

7.2.5 Laborie Medical Recent Development

7.3 Urogyn B.V.

7.3.1 Urogyn B.V. Company Information

7.3.2 Urogyn B.V. Business Overview

7.3.3 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Urogyn B.V. Injectable Implant Urinary Incontinence Device Products Offered

7.3.5 Urogyn B.V. Recent Development

8 Injectable Implant Urinary Incontinence Device Manufacturing Cost Analysis

8.1 Injectable Implant Urinary Incontinence Device Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Injectable Implant Urinary Incontinence Device

8.4 Injectable Implant Urinary Incontinence Device Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Injectable Implant Urinary Incontinence Device Distributors List

9.3 Injectable Implant Urinary Incontinence Device Customers

10 Injectable Implant Urinary Incontinence Device Market Dynamics

10.1 Injectable Implant Urinary Incontinence Device Industry Trends

10.2 Injectable Implant Urinary Incontinence Device Market Drivers

10.3 Injectable Implant Urinary Incontinence Device Market Challenges

10.4 Injectable Implant Urinary Incontinence Device Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Injectable Implant Urinary Incontinence Device Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Injectable Implant Urinary Incontinence Device Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Injectable Implant Urinary Incontinence Device Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Injectable Implant Urinary Incontinence Device Sales (K Units) by Region (2020-2025)

Table 5. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Region (2020-2025)

Table 6. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Injectable Implant Urinary Incontinence Device Revenue Share by Region (2020-2025)

Table 8. Global Injectable Implant Urinary Incontinence Device Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Injectable Implant Urinary Incontinence Device Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Injectable Implant Urinary Incontinence Device Revenue Share Forecast by Region (2026-2031)

Table 12. Global Injectable Implant Urinary Incontinence Device Sales by Type (K Units) & (2020-2025)

Table 13. Global Injectable Implant Urinary Incontinence Device Sales Share by Type (2020-2025)

Table 14. Global Injectable Implant Urinary Incontinence Device Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Injectable Implant Urinary Incontinence Device Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Injectable Implant Urinary Incontinence Device Sales by Type (K Units) & (2026-2031)

Table 17. Global Injectable Implant Urinary Incontinence Device Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Injectable Implant Urinary Incontinence Device Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Injectable Implant Urinary Incontinence Device Sales by Application (K Units) & (2020-2025)

Table 21. Global Injectable Implant Urinary Incontinence Device Sales Share by Application (2020-2025)

Table 22. Global Injectable Implant Urinary Incontinence Device Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Injectable Implant Urinary Incontinence Device Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Injectable Implant Urinary Incontinence Device Sales by Application (K Units) & (2026-2031)

Table 25. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Injectable Implant Urinary Incontinence Device Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Injectable Implant Urinary Incontinence Device Application

Table 28. Global Injectable Implant Urinary Incontinence Device Sales by Company (K Units) & (2020-2025)

Table 29. Global Injectable Implant Urinary Incontinence Device Sales Share by Company (2020-2025)

Table 30. Global Injectable Implant Urinary Incontinence Device Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Injectable Implant Urinary Incontinence Device Revenue Share by Company (2020-2025)

Table 32. Global Injectable Implant Urinary Incontinence Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2024)

Table 33. Global Market Injectable Implant Urinary Incontinence Device Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Product Type & Application

Table 36. Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025) & (K Units)

Table 39. North America Injectable Implant Urinary Incontinence Device Sales Market Share by Company (2020-2025)

Table 40. North America Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Injectable Implant Urinary Incontinence Device Revenue Market Share by Company (2020-2025)

Table 42. North America Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025) & (K Units)

Table 43. North America Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2025)

Table 44. North America Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025) & (K Units)

Table 45. North America Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2025)

Table 46. Europe Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025) & (K Units)

Table 47. Europe Injectable Implant Urinary Incontinence Device Sales Market Share by Company (2020-2025)

Table 48. Europe Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Injectable Implant Urinary Incontinence Device Revenue Market Share by Company (2020-2025)

Table 50. Europe Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025) & (K Units)

Table 51. Europe Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2025)

Table 52. Europe Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025) & (K Units)

Table 53. Europe Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2025)

Table 54. China Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025) & (K Units)

Table 55. China Injectable Implant Urinary Incontinence Device Sales Market Share by Company (2020-2025)

Table 56. China Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Injectable Implant Urinary Incontinence Device Revenue Market Share by Company (2020-2025)

Table 58. China Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025) & (K Units)

Table 59. China Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2025)

Table 60. China Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025) & (K Units)

Table 61. China Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2025)

Table 62. Japan Injectable Implant Urinary Incontinence Device Sales by Company (2020-2025) & (K Units)

Table 63. Japan Injectable Implant Urinary Incontinence Device Sales Market Share by Company (2020-2025)

Table 64. Japan Injectable Implant Urinary Incontinence Device Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Injectable Implant Urinary Incontinence Device Revenue Market Share by Company (2020-2025)

Table 66. Japan Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025) & (K Units)

Table 67. Japan Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2025)

Table 68. Japan Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025) & (K Units)

Table 69. Japan Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2025)

Table 70. Boston Scientific Company Information

Table 71. Boston Scientific Description and Business Overview

Table 72. Boston Scientific Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Boston Scientific Injectable Implant Urinary Incontinence Device Product

Table 74. Boston Scientific Recent Development

Table 75. Laborie Medical Company Information

Table 76. Laborie Medical Description and Business Overview

Table 77. Laborie Medical Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Laborie Medical Injectable Implant Urinary Incontinence Device Product

Table 79. Laborie Medical Recent Development

Table 80. Urogyn B.V. Company Information

Table 81. Urogyn B.V. Description and Business Overview

Table 82. Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Urogyn B.V. Injectable Implant Urinary Incontinence Device Product

Table 84. Urogyn B.V. Recent Development

Table 85. Production Base and Market Concentration Rate of Raw Material

Table 86. Key Suppliers of Raw Materials

Table 87. Injectable Implant Urinary Incontinence Device Distributors List

Table 88. Injectable Implant Urinary Incontinence Device Customers List

Table 89. Injectable Implant Urinary Incontinence Device Market Trends

Table 90. Injectable Implant Urinary Incontinence Device Market Drivers

Table 91. Injectable Implant Urinary Incontinence Device Market Challenges

Table 92. Injectable Implant Urinary Incontinence Device Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Injectable Implant Urinary Incontinence Device Product Picture

Figure 2. Global Injectable Implant Urinary Incontinence Device Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Type in 2024 & 2031

Figure 4. Stress Incontinence Product Picture

Figure 5. Urge Incontinence Product Picture

Figure 6. Overflow Incontinence Product Picture

Figure 7. Functional Incontinence Product Picture

Figure 8. Others Product Picture

Figure 9. Global Injectable Implant Urinary Incontinence Device Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 10. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Application in 2024 & 2031

Figure 11. Hospitals and Clinics Examples

Figure 12. Ambulatory Surgery Centres Examples

Figure 13. Others Examples

Figure 14. Global Injectable Implant Urinary Incontinence Device Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Injectable Implant Urinary Incontinence Device Sales Growth Rate (2020-2031) & (US$ Million)

Figure 16. Global Injectable Implant Urinary Incontinence Device Sales (K Units) Growth Rate (2020-2031)

Figure 17. Global Injectable Implant Urinary Incontinence Device Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 18. Injectable Implant Urinary Incontinence Device Report Years Considered

Figure 19. Global Market Injectable Implant Urinary Incontinence Device Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 20. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Region: 2020 VS 2024

Figure 21. North America Injectable Implant Urinary Incontinence Device Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. North America Injectable Implant Urinary Incontinence Device Sales (K Units) Growth Rate (2020-2031)

Figure 23. Europe Injectable Implant Urinary Incontinence Device Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Europe Injectable Implant Urinary Incontinence Device Sales (K Units) Growth Rate (2020-2031)

Figure 25. China Injectable Implant Urinary Incontinence Device Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. China Injectable Implant Urinary Incontinence Device Sales (K Units) Growth Rate (2020-2031)

Figure 27. Japan Injectable Implant Urinary Incontinence Device Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Injectable Implant Urinary Incontinence Device Sales (K Units) Growth Rate (2020-2031)

Figure 29. Global Injectable Implant Urinary Incontinence Device Revenue Share by Type (2020-2025)

Figure 30. Global Injectable Implant Urinary Incontinence Device Sales Share by Type (2026-2031)

Figure 31. Global Injectable Implant Urinary Incontinence Device Revenue Share by Type (2026-2031)

Figure 32. Global Injectable Implant Urinary Incontinence Device Revenue Share by Application (2020-2025)

Figure 33. Global Injectable Implant Urinary Incontinence Device Revenue Growth Rate by Application in 2020 & 2024

Figure 34. Global Injectable Implant Urinary Incontinence Device Sales Share by Application (2026-2031)

Figure 35. Global Injectable Implant Urinary Incontinence Device Revenue Share by Application (2026-2031)

Figure 36. Global Injectable Implant Urinary Incontinence Device Sales Share by Company (2024)

Figure 37. Global Injectable Implant Urinary Incontinence Device Revenue Share by Company (2024)

Figure 38. Global 5 Largest Injectable Implant Urinary Incontinence Device Players Market Share by Revenue in Injectable Implant Urinary Incontinence Device: 2020 & 2024

Figure 39. Injectable Implant Urinary Incontinence Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 40. Manufacturing Cost Structure of Injectable Implant Urinary Incontinence Device

Figure 41. Manufacturing Process Analysis of Injectable Implant Urinary Incontinence Device

Figure 42. Injectable Implant Urinary Incontinence Device Industrial Chain

Figure 43. Channels of Distribution (Direct Vs Distribution)

Figure 44. Distributors Profiles

Figure 45. Bottom-up and Top-down Approaches for This Report

Figure 46. Data Triangulation

Figure 47. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What is the annual compound growth rate of the global Injectable Implant Urinary Incontinence Device market size from 2025 to 2031? shouQi

Which companies rank high in the global Injectable Implant Urinary Incontinence Device market? shouQi

What was the global market size of Injectable Implant Urinary Incontinence Device in 2031? shouQi

What was the global market size of Injectable Implant Urinary Incontinence Device in 2025? shouQi

Related Reports

Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 121
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 104
USD 2900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 118
USD 4900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2025
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 67
USD 2900.00
(Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 82
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-04-12
Pages: 75
USD 4900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-17
Pages: 74
USD 2900.00
(Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-10
Pages: 82
USD 3950.00
(Single User License)

Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 121
USD 3950.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 104
USD 2900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 118
USD 4900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2025
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 67
USD 2900.00 (Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 82
USD 3950.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-04-12
Pages: 75
USD 4900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-17
Pages: 74
USD 2900.00 (Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-10
Pages: 82
USD 3950.00 (Single User License)